The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Open accessAbstract
Neurofibromatosis 1 (NF1) is a common neurocutaneous condition with an autosomal dominant pattern of inheritance. The complications are diverse and disease expression varies, even within families. Progress in molecular biology and neuroimaging and the development of mouse models have helped to elucidate the aetiology of NF1 and its clinical manifestations. Furthermore, these advances have raised the prospect of therapeutic intervention for this complex and distressing disease. Members of the United Kingdom Neurofibromatosis Association Clinical Advisory Board collaborated to produce a consensus statement on the current guidelines for diagnosis and management of NF1. The proposals are based on published clinical studies and on the pooled knowledge of experts in neurofibromatosis with experience of providing multidisciplinary clinical and molecular services for NF1 patients. The consensus statement discusses the diagnostic criteria, major differential diagnoses, clinical manifestations and the present strategies for monitoring and management of NF1 complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,475
Trofatter, J. (1993) · Cell · doi:10.1016/0092-8674(93)90406-g · Cited by 1,403
Brown, A. S., Brummel‐Smith, K., Burgess, L., D'Agostino, R. B., Goldschmidt, J. W., Halter, J. B., Hazzard, W. R., Jahnigen, D. W., Phelps, C., Raskind, M., et al. (1988) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1988.tb02362.x · Cited by 1,331
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
Evans, D. G. R., Baser, M. E., McGaughran, J., Sharif, S., Howard, E., & Moran, A. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.5.311 · Cited by 1,282
Self-citationThe neurofibromatosis type 1 gene encodes a protein related to GAP
Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90024-9 · Cited by 1,095
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082
(1988) · PubMed · Cited by 817
Principles and Practice of Medical Genetics
Pembrey, M. (1984) · Archives of Disease in Childhood · doi:10.1136/adc.59.2.192 · Cited by 776
VON RECKLINGHAUSEN NEUROFIBROMATOSIS: A CLINICAL AND POPULATION STUDY IN SOUTH-EAST WALES
HUSON, S. M., HARPER, P. S., & COMPSTON, D. A. S. (1988) · Brain · doi:10.1093/brain/111.6.1355 · Cited by 686
Self-citationThe nature and frequency of cognitive deficits in children with neurofibromatosis type 1
Hyman, S. L., Shores, A., & North, K. N. (2005) · Neurology · doi:10.1212/01.wnl.0000179303.72345.ce · Cited by 637
Packer, R. J., Ater, J., Allen, J., Phillips, P., Geyer, R., Nicholson, H. S., Jakacki, R., Kurczynski, E., Needle, M., Finlay, J., et al. (1997) · Journal of Neurosurgery · doi:10.3171/jns.1997.86.5.0747 · Cited by 636
A Clinical Study of Type 2 Neurofibromatosis
(1992) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068699 · Cited by 634
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.
Ferner, R. E., & Gutmann, D. H. (2002) · PubMed · Cited by 603
Self-citationHuson, S. M., Compston, D. A., Clark, P., & Harper, P. S. (1989) · Journal of Medical Genetics · doi:10.1136/jmg.26.11.704 · Cited by 540
Self-citationMessiaen, L. M., Callens, T., Mortier, G., Beysen, D., Vandenbroucke, I., Van Roy, N., Speleman, F., & Paepe, A. D. (2000) · Human Mutation · doi:10.1002/1098-1004(200006)15:6<541::aid-humu6>3.0.co;2-n · Cited by 521
Miettinen, M., Fetsch, J. F., Sobin, L. H., & Lasota, J. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000176433.81079.bd · Cited by 507
Listernick, R., Louis, D. N., Packer, R. J., & Gutmann, D. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410204 · Cited by 478
Evans, D. G. R., Moran, A., King, A., Saeed, S., Gurusinghe, N., & Ramsden, R. (2005) · Otology & Neurotology · doi:10.1097/00129492-200501000-00016 · Cited by 418
Self-citationDiagnostic criteria for schwannomatosis
MacCollin, M., Chiocca, E. A., Evans, D. G., Friedman, J. M., Horvitz, R., Jaramillo, D., Lev, M., Mautner, V. F., Niimura, M., Plotkin, S. R., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000163982.78900.ad · Cited by 417
Self-citationCardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force
Friedman, J. M., Arbiser, J., Epstein, J. A., Gutmann, D. H., Huot, S. J., Lin, A. E., Mcmanus, B., & Korf, B. R. (2002) · Genetics in Medicine · doi:10.1097/00125817-200205000-00002 · Cited by 402
Li, W., Cui, Y., Kushner, S. A., Brown, R. A. M., Jentsch, J. D., Frankland, P. W., Cannon, T. D., & Silva, A. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.09.043 · Cited by 402
Korf, B. R. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1<31::aid-ajmg7>3.0.co;2-w · Cited by 390
Ueber die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen
Recklinghausen, F. V. (1882) · A. Hirschwald eBooks · Cited by 387
The clinical and diagnostic implications mosaicism in the neurofibromatoses
Ruggieri, M., & Huson, S. M. (2001) · Neurology · doi:10.1212/wnl.56.11.1433 · Cited by 387
Self-citationSharif, S., Ferner, R., Birch, J. M., Gillespie, J. E., Gattamaneni, H. R., Baser, M. E., & Evans, D. G. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8349 · Cited by 377
Self-citationDaston, M. M., Scrable, H., Nordlund, M., Sturbaum, A. K., Nissen, L. M., & Ratner, N. (1992) · Neuron · doi:10.1016/0896-6273(92)90270-n · Cited by 314
Elevated Risk for MPNST in NF1 Microdeletion Patients
De Raedt, T., Brems, H., Wolkenstein, P., Vidaud, D., Pilotti, S., Perrone, F., Mautner, V., Frahm, S., Sciot, R., & Legius, E. (2003) · The American Journal of Human Genetics · doi:10.1086/374821 · Cited by 310
Dasgupta, B., Yi, Y., Chen, D. Y., Weber, J. D., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4058 · Cited by 308
Identification of the neurofibromatosis type 1 gene product.
Gutmann, D. H., Wood, D. L., & Collins, F. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9658 · Cited by 278
Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain.
DiPaolo, D. P., Zimmerman, R. A., Rorke, L. B., Zackai, E. H., Bilaniuk, L. T., & Yachnis, A. T. (1995) · Radiology · doi:10.1148/radiology.195.3.7754001 · Cited by 274
North, K. N., Riccardi, V., Samango-Sprouse, C., Ferner, R., Moore, B., Legius, E., Ratner, N., & Denckla, M. B. (1997) · Neurology · doi:10.1212/wnl.48.4.1121 · Cited by 269
Self-citationMorphologic studies of the liver cell dysplasia
Watanabe, S., Okita, K., Harada, T., Kodama, T., Numa, Y., Takemoto, T., & Takahashi, T. (1983) · Cancer · doi:10.1002/1097-0142(19830615)51:12<2206::aid-cncr2820511209>3.0.co;2-b · Cited by 258
Treatment of ADHD in neurofibromatosis type 1
Mautner, V.-F., Kluwe, L., Thakker, S. D., & Leark, R. A. (2002) · Developmental Medicine and Child Neurology · doi:10.1017/s0012162201001876 · Cited by 249
Neurological complications of neurofibromatosis type 1 in adulthood
Créange, A., Zeller, J., Rostaing-Rigattieri, S., Brugières, P., Degos, J.-D., Revuz, J., & Wolkenstein, P. (1999) · Brain · doi:10.1093/brain/122.3.473 · Cited by 247
Osseous Manifestations of Neurofibromatosis in Childhood
Crawford, A. H., & Bagamery, N. (1986) · Journal of Pediatric Orthopaedics · doi:10.1097/01241398-198601000-00015 · Cited by 240
Ferner, R. E. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.3.353 · Cited by 217
Self-citationQuality-of-Life Impairment in Neurofibromatosis Type 1: A Cross-sectional Study of 128 Cases
Wolkenstein, P., Zeller, J., Revuz, J., Ecosse, E., & Leplège, A. (2001) · Archives of Dermatology · doi:10.1001/archderm.137.11.1421 · Cited by 208
North, K., Joy, P., Yuille, D., Cocks, N., Mobbs, E., Hutchins, P., McHugh, K., & de Silva, M. (1994) · Neurology · doi:10.1212/wnl.44.5.878 · Cited by 208
Plexiform neurofibromas in NF1: Toward biologic-based therapy
Packer, R. J., Gutmann, D. H., Rubenstein, A., Viskochil, D., Zimmerman, R. A., Vezina, G., Small, J., & Korf, B. (2002) · Neurology · doi:10.1212/wnl.58.10.1461 · Cited by 186
Intellectual impairment in neurofibromatosis 1
Ferner, R. E., Hughes, R. A. C., & Weinman, J. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00022-6 · Cited by 183
Self-citationCognitive impairment in neurofibromatosis type 1
Ozonoff, S. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1<45::aid-ajmg9>3.0.co;2-j · Cited by 172
Neurofibromatosis type 1 and pregnancy
Dugoff, L., & Sujansky, E. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19961202)66:1<7::aid-ajmg2>3.0.co;2-r · Cited by 168
Diagnostic Outcome in Children With Multiple Cafe au Lait Spots
Korf, B. R. (1992) · PEDIATRICS · doi:10.1542/peds.90.6.924 · Cited by 157
Clinical and Genetic Characteristics of Patients with Neurofibromatosis Type 1 and Pheochromocytoma
Bausch, B., Borozdin, W., & Neumann, H. P. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmc066006 · Cited by 154
NF1 Gene Mutations Represent the Major Molecular Event Underlying Neurofibromatosis-Noonan Syndrome
Luca, A. D., Bottillo, I., Sárközy, A., Carta, C., Neri, C., Bellacchio, E., Schirinzi, A., Conti, E., Zampino, G., Battaglia, A., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/498454 · Cited by 154
Decreased bone mineral density in patients with neurofibromatosis 1
Lammert, M., Kappler, M., Mautner, V., Lammert, K., Störkel, S., Friedman, J. M., & Atkins, D. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1940-2 · Cited by 143
Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children
DeBella, K., Poskitt, K. J., Szudek, J., & Friedman, J. M. (2000) · Neurology · doi:10.1212/wnl.54.8.1646 · Cited by 139
Late-onset optic pathway tumors in children with neurofibromatosis 1
Listernick, R., Ferner, R. E., Piersall, L. D., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144341.16830.01 · Cited by 127
Self-citationFerner, R. E., Chaudhuri, R., Bingham, J., et al. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.5.492 · Cited by 127
Self-citationCranial MR imaging in neurofibromatosis
Bognanno, J. R., Edwards, M. K., Lee, T., Dunn, D. W., Roos, K. L., & Klatte, E. C. (1988) · American Journal of Roentgenology · doi:10.2214/ajr.151.2.381 · Cited by 115
Cambiaghi, S., Restano, L., & Caputo, R. (2004) · Pediatric Dermatology · doi:10.1111/j.0736-8046.2004.21201.x · Cited by 106
Psychological disturbance and sleep disorders in children with neurofibromatosis type 1
Johnson, H., Wiggs, L. D., Stores, G., & Huson, S. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205000460 · Cited by 93
Self-citationMolecular diagnosis of neurofibromatosis type 1: 2 years experience
Griffiths, S., Thompson, P., Frayling, I. M., & Upadhyaya, M. (2006) · Familial Cancer · doi:10.1007/s10689-006-9001-3 · Cited by 90
Self-citationProgesterone receptor expression in neurofibromas.
McLaughlin, M. E., & Jacks, T. (2003) · PubMed · Cited by 83
Neurofibromatous neuropathy in neurofibromatosis 1 (NF1)
Ferner, R. E., Hughes, R. A. C., Hall, S. M., Upadhyaya, M., & Johnson, M. R. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.021683 · Cited by 82
Self-citationKhosrotehrani, K., Bastuji‐Garin, S., Riccardi, V. M., Birch, P. H., Friedman, J. M., & Wolkenstein, P. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30394 · Cited by 80
Natural history of neurofibromatosis 1–associated optic nerve glioma in mice
Bajenaru, M. L., Garbow, J. R., Perry, A., Hernandez, M. R., & Gutmann, D. H. (2004) · Annals of Neurology · doi:10.1002/ana.20337 · Cited by 74
Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients
Lammert, M., Mautner, V., & Kluwe, L. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-16 · Cited by 58
Preimplantation diagnosis for neurofibromatosis
Verlinsky, Y., Rechitsky, S., Verlinsky, O., et al. (2002) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61809-3 · Cited by 52
Principles and practice of medical genetics (2nd edn)
Ponder, B. A. J. (1991) · Trends in Genetics · doi:10.1016/0168-9525(91)90372-w · Cited by 51
Multifocal glomus tumours of the fingers in two patients with neurofibromatosis type 1: Figure 1
SMET, L. D., Sciot, R., & Legius, E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.8.e45 · Cited by 39
Special issues in the management of gliomas in children with neurofibromatosis 1
Pollack, I. F., & Mulvihi, J. (1996) · Journal of Neuro-Oncology · doi:10.1007/bf00250204 · Cited by 33
Cited by
Gutmann, D. H., Ferner, R. E., Listernick, R. H., Korf, B. R., Wolters, P. L., & Johnson, K. J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.4 · Cited by 862
Self-citationNeurofibromatosis Type 1 Revisited
Williams, V. C., Lucas, J., Babcock, M. A., Gutmann, D. H., Korf, B., & Maria, B. L. (2009) · Pediatrics · doi:10.1542/peds.2007-3204 · Cited by 695
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Kauff, N. D., Khan, S., Klein, C., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0003 · Cited by 650
Neurofibromatosis type 1: a multidisciplinary approach to care
Hirbe, A. C., & Gutmann, D. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70063-8 · Cited by 626
Keppler‐Noreuil, K. M., Rios, J. J., Parker, V. E. R., Semple, R. K., Lindhurst, M. J., Sapp, J. C., Alomari, A., Ezaki, M., Dobyns, W., & Biesecker, L. G. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36836 · Cited by 580
Metadata
- Authors
- Ferner, R. E., Huson, S. M., Thomas, N., Moss, C., Willshaw, H., Evans, D. G., Upadhyaya, M., Towers, R., Gleeson, M., Steiger, C., & Kirby, A.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2006-11-14
- Volume
- 44
- Issue
- 2
- Pages
- 81-88
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W1997887695
- Cited by
- 1,053
- References
- 62
- FWCI
- 17.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.